Animalcare is a sustainable pan-European animal health company working in a growing market
On 12 July 2017 shareholders approved the acquisition of Ecuphar NV to create a specialist pan-European animal health business with combined annual revenues of over £80m. The Enlarged Group now represents a growing, highly cash generative dividend paying company with a solid pipeline of new products.
Animalcare Group plc remains focussed on growing its veterinary business
Animalcare is a leading developer and supplier of veterinary pharmaceutical products with direct sales in seven countries, exporting to around 50 markets worldwide and owners of 50 licenced drugs, eight vaccines and over 100 care and nutraceutical products.